Carl Zeiss Meditec
Medical-device arm of the Carl Zeiss industrial group. Core focus is ophthalmic diagnostics and surgical visualization — a different commercial domain from general-radiology imaging. Publicly listed; one of the global leaders in ophthalmic OCT (optical coherence tomography), perimetry, and ophthalmic surgical microscopy.
Company history
- 1846 — Carl Zeiss founded in Jena, Germany. Originally scientific optics.
- 2002 — Carl Zeiss Meditec AG established as a separately listed subsidiary focused on medical technology.
- 2000s–2010s — OCT becomes the dominant retinal imaging modality worldwide; the Cirrus platform establishes Zeiss as a category leader. Acquisition of Optronics, IanTECH, and others.
- 2017–present — Cirrus 6000 generation, OCT-A integration, integration with retinal-disease AI partners.
Product line
- Cirrus OCT family — spectral-domain OCT for retinal and anterior-segment imaging. Cirrus 5000 / 6000 generations widely deployed.
- Humphrey Visual Field Analyzer (HFA) — perimetry workhorse for glaucoma workup; HFA3 current generation.
- Surgical microscopes — OPMI Lumera (cataract / anterior-segment), Lumera 700, KINEVO 900 (vitreoretinal / neurosurgery / ENT). Heads-up surgery via NGENUITY-class digital visualization on partner platforms.
- IOLMaster 700 — swept-source biometry for cataract surgery planning. Category-dominant.
- ATLAS corneal topographer and CIRRUS HD-OCT widefield modules.
Market position
- Ophthalmic OCT: top-tier globally, in close competition with Heidelberg Engineering (Spectralis) and Topcon. Cirrus dominates U.S. retinal-clinic installed base; Spectralis and Topcon hold notable share in glaucoma and Asia-Pacific respectively.
- Perimetry: HFA is the de facto standard for clinical visual-field testing; cross-vendor data interchange remains poor, locking practices in.
- Ophthalmic surgical microscopy: alongside Leica, the dominant supplier of high-end ophthalmic surgical visualization.
- General radiology / cross-sectional imaging: not present.
Refurb posture
- Software / firmware version is the price-determining variable on used Cirrus and HFA — analytics packages and normative databases are version-locked.
- Vendor lock-in on serial patient comparison — a clinic that switches OCT or perimetry vendors creates discontinuity in every patient's longitudinal record. Practical effect: refurbs of the same vendor are heavily preferred over cross-vendor migration.
- Cirrus refurb supply is healthy on earlier 5000-generation; HFA II and HFA III refurb units are common in academic / community ophthalmology turnover.